Introduction: The Unified Standard for Pharmaceutical Closures
In the pharmaceutical packaging industry, standards provide the essential framework that ensures product safety, quality, and regulatory compliance. Among the most significant developments in recent years is the publication of ISO 8872:2022 – Aluminium caps and aluminium/plastic caps for infusion bottles and injection vials – General requirements and test methods. This landmark standard represents the first comprehensive consolidation of requirements for both aluminum caps and aluminum-plastic combination caps, unifying what were previously two separate standards into a single, harmonized document.
Published in November 2022 by ISO/TC 76 (Transfusion, infusion and injection, and blood processing equipment for medical and pharmaceutical use), this third edition supersedes both ISO 8872:2003 (which covered aluminum caps) and ISO 10985:2009 (which covered aluminum-plastic combination caps). The consolidation reflects the industry’s recognition that these two closure types share fundamental requirements and test methods, and that a unified approach benefits manufacturers, regulators, and healthcare providers alike.
At Vialab Pharmaceutical Packaging Co., Ltd. , we design and manufacture both aluminum caps and aluminum-plastic combination caps in full compliance with ISO 8872:2022. Our advanced production lines and cleanroom facilities enable us to produce closures that meet the rigorous requirements of this standard, ensuring consistent quality, integrity, and compliance for global healthcare partners.
This article provides a comprehensive examination of ISO 8872:2022, exploring its scope, key requirements, test methods, and practical implications for pharmaceutical manufacturers.
1. Scope and Applicability
ISO 8872:2022 specifies general requirements and test methods for aluminium caps and aluminium/plastic caps intended for use on infusion bottles and/or injection vials. The standard applies to closures manufactured in accordance with the relevant product-specific standards:
- ISO 8362-6 – Injection containers and accessories — Caps made of aluminium-plastics combinations for injection vials
- ISO 8536-7 – Infusion equipment for medical use — Caps made of aluminium-plastics combinations for infusion bottles
The standard spans 13 pages and provides a detailed framework for the design, manufacture, testing, and quality control of these critical packaging components.
1.1 Important Clarification: Not Primary Packaging
A critical distinction made in ISO 8872:2022 is that aluminium caps and aluminium/plastic caps are not considered primary packaging materials that come into direct contact with pharmaceutical preparations. This is an important regulatory distinction: unlike the glass vial or the elastomeric stopper, the cap does not contact the drug product. Consequently, the standard’s requirements focus primarily on mechanical protection characteristics, dimensional accuracy, and functional performance rather than on extractables, leachables, or biocompatibility.
2. Key Changes from Previous Standards
ISO 8872:2022 introduces several significant changes compared to its predecessors. According to the standard’s documentation, the main modifications are:
2.1 Integration of ISO 10985:2009
The most substantial change is the consolidation of ISO 10985:2009 (aluminum-plastic combination caps) into ISO 8872:2022. Previously, manufacturers of aluminum-plastic caps had to reference ISO 10985:2009, while aluminum cap manufacturers referenced ISO 8872:2003. The new standard eliminates this fragmentation, providing a single source of requirements for both closure types.
2.2 New Terminology
The 2022 edition introduces updated and expanded terminology definitions, ensuring clarity and consistency in the interpretation of requirements across the industry.
2.3 New Annex A – Type Drawings
Annex A provides informative type drawings for aluminum and aluminum-plastic caps, offering visual guidance on design configurations and dimensional features.
2.4 New Annex B – Opening and Tear-Off Forces
Annex B is a normative (mandatory) annex that specifies the test methods and acceptance criteria for opening and tear-off forces, providing standardized procedures that ensure consistent evaluation across different laboratories and manufacturers.
3. Core Requirements of ISO 8872:2022
The standard’s requirements are organized into several key sections, each addressing a specific aspect of cap performance and quality.
3.1 General Requirements
Section 4.1 establishes the general framework for compliance, emphasizing that caps must fulfill their intended functions throughout the product lifecycle, including manufacturing, filling, sterilization, transportation, storage, and administration.
3.2 Aluminium Component Requirements (Section 4.2)
The aluminum component must meet stringent specifications across multiple parameters:
Mechanical Characteristics (4.2.1): The aluminum alloy must demonstrate adequate tensile strength and elongation to withstand the crimping process without cracking or fracturing. These mechanical properties are verified through standardized tensile testing.
Chemical Composition (4.2.2): The aluminum alloy must meet specified chemical composition requirements to ensure consistent material properties and performance.
Dimensions (4.2.3): Critical dimensions must be maintained within specified tolerances to ensure proper fitment with the vial neck finish and elastomeric stopper.
Contamination (4.2.4): The aluminum component must be free from contaminants that could compromise product quality or patient safety.
Earing (4.2.5): Earing—the formation of uneven edges during deep drawing—must be controlled to ensure consistent crimping performance.
Other Defects (4.2.6): The standard addresses various other defects that could affect cap performance, including surface imperfections, coating defects, and dimensional anomalies.
3.3 Plastic Component Requirements (Section 4.3)
For aluminum-plastic combination caps, the plastic component must also meet specific requirements:
Mechanical Characteristics (4.3.1): The plastic material must maintain its mechanical properties through sterilization and throughout the product’s shelf life.
Chemical Composition (4.3.2): The plastic material must be suitable for pharmaceutical applications and compatible with the intended sterilization methods.
Dimensions (4.3.3): Dimensional tolerances for the plastic component must be maintained to ensure proper assembly and function.
Contamination (4.3.4): The plastic component must be free from contaminants.
Other Defects (4.3.5): The standard addresses defects specific to plastic components, such as flash, sink marks, and surface imperfections.
3.4 Functional Requirements (Section 4.4)
This section addresses the performance characteristics of the complete cap assembly:
Opening and Tear-Off Forces for Aluminium Caps (4.4.1): The force required to open or tear off the cap must fall within specified ranges to ensure both security and ease of use.
Joining of Aluminium and Plastic Component (4.4.2): For combination caps, the bond between the aluminum and plastic components must withstand normal handling, transportation, and storage without delamination.
Opening and Tear-Off Forces for Aluminium/Plastic Caps (4.4.3): Specific force requirements are established for the removal of the plastic component (flip-off button or tear-off tab).
Mechanical Requirements after Sterilization (4.4.4): The cap must maintain its mechanical properties after exposure to the intended sterilization method(s), including moist heat sterilization at 121°C and irradiation sterilization.
4. Test Methods (Section 5)
ISO 8872:2022 specifies detailed test methods to verify compliance with the standard’s requirements.
4.1 Mechanical Characteristics Testing (5.2)
Tensile testing is performed in accordance with ISO 6892-1 to verify the mechanical properties of the aluminum component. The testing apparatus must comply with ISO 7500-1 Class 1 requirements for force measurement systems.
4.2 Chemical Composition Testing (5.3)
The chemical composition of the aluminum alloy is verified through appropriate analytical methods to ensure compliance with specified requirements.
4.3 Dimensional Verification (5.4)
Critical dimensions are measured using calibrated instruments to ensure compliance with specified tolerances.
4.4 Earing Testing (5.5)
Earing is evaluated to ensure that uneven edges do not compromise crimping performance.
4.5 Opening and Tear-Off Forces Testing (5.6)
Opening and tear-off forces are measured using a tensile testing machine with a crosshead speed of 100 mm/min. For 13 mm aluminum-plastic caps, the radius of the metal finger is specified as 8 mm. The test methods are detailed in Annex B (normative), which provides standardized procedures for consistent evaluation.
4.6 Test Methods after Sterilization (5.7)
Stability of Coating on Aluminium (5.7.1): Surface coatings on the aluminum component must remain stable through sterilization cycles without degradation or flaking.
Test Method for Premature Opening and Deformation (5.7.2): The cap must withstand sterilization without premature opening or deformation that could compromise the seal.
5. Packaging and Marking (Sections 6 and 7)
5.1 Packaging Requirements (Section 6)
The standard specifies packaging requirements to ensure that caps reach the pharmaceutical manufacturer in proper condition. Packaging must protect the caps from contamination, mechanical damage, and environmental factors during transportation and storage.
5.2 Marking Requirements (Section 7)
Caps must be marked with appropriate information to ensure traceability and proper identification. Marking requirements typically include the manufacturer’s identification, batch or lot number, and other relevant information.
6. The Standard’s Role in Container Closure Integrity
While ISO 8872:2022 focuses on the cap itself, the cap’s ultimate performance must be evaluated as part of the complete container closure system. As EU GMP Annex 1 states, an aseptically filled vial is not regarded as fully closed until the aluminum cap has been crimped onto the stoppered vial.
Container Closure Integrity (CCI) is vital to ensuring the sterility and safety of parenteral pharmaceuticals. The container closure system includes all packaging components that, when securely sealed, protect a drug product from contamination and degradation while maintaining its efficacy and safety throughout its shelf life.
ISO 8872:2022 contributes to CCI by ensuring that:
- The aluminum component provides adequate mechanical force to maintain stopper compression
- The cap withstands sterilization without degradation
- Opening and tear-off forces are within specified ranges
- The cap provides tamper-evident functionality
These requirements, when properly implemented, help ensure that the container closure system maintains its integrity throughout the product’s shelf life.
7. Practical Implications for Pharmaceutical Manufacturers
7.1 Regulatory Compliance
Compliance with ISO 8872:2022 is essential for regulatory submissions worldwide. Regulatory authorities expect that closure systems meet internationally recognized standards, and deviation from these standards requires extensive justification.
7.2 Supplier Qualification
When selecting a supplier for aluminum caps or aluminum-plastic combination caps, pharmaceutical manufacturers should verify that the supplier’s products meet the requirements of ISO 8872:2022. This includes reviewing:
- Material certifications (chemical composition and mechanical properties)
- Dimensional inspection reports
- Opening and tear-off force test results
- Sterilization validation data
- Packaging and marking compliance
7.3 Product Development
For new drug products, the selection of the closure system should be guided by ISO 8872:2022 requirements. Factors to consider include:
- Compatibility with the specific vial or bottle design
- Suitability for the intended sterilization method
- Opening force requirements for the target user population
- Tamper-evident feature requirements
7.4 Quality Control
Manufacturers should implement quality control programs that verify ongoing compliance with the standard. This includes:
- Incoming inspection of caps
- In-process monitoring during capping operations
- Finished product testing (including CCI testing)
- Periodic revalidation of the capping process
8. The Evolution of Pharmaceutical Closure Standards
The publication of ISO 8872:2022 represents the latest step in the evolution of pharmaceutical closure standards:
- ISO 8872:1988 – The original standard covering aluminum caps for transfusion, infusion, and injection bottles
- ISO 8872:2003 – The second edition, which expanded and updated the requirements for aluminum caps
- ISO 10985:2009 – The separate standard covering aluminum-plastic combination caps
- ISO 8872:2022 – The third edition, which consolidates both previous standards into a unified document
This evolution reflects the industry’s growing recognition of the need for harmonized requirements across closure types, simplified regulatory compliance, and consistent quality standards.
9. Vialab’s Commitment to Standards Compliance
At Vialab Pharmaceutical Packaging Co., Ltd. , we recognize that compliance with ISO 8872:2022 is not merely a regulatory obligation—it is a fundamental commitment to patient safety and product quality.
Our aluminum caps and aluminum-plastic combination caps are manufactured to meet the stringent requirements of this standard, with:
- Pharmaceutical-grade aluminum alloys meeting specified mechanical properties and chemical composition
- High-quality plastic components validated for pharmaceutical applications
- Precision manufacturing ensuring dimensional accuracy
- Comprehensive testing including opening force, dimensional verification, and visual inspection
- Cleanroom manufacturing ensuring product cleanliness
- Rigorous quality control at every stage of production
Whether you require standard 13 mm or 20 mm aluminum caps, aluminum-plastic combination caps with flip-off or tear-off designs, or customized solutions for specialized applications, Vialab delivers precision, safety, and reliability in every component.
Conclusion
ISO 8872:2022 represents a significant milestone in pharmaceutical packaging standards. By consolidating the requirements for aluminum caps and aluminum-plastic combination caps into a single, harmonized document, the standard simplifies regulatory compliance, promotes consistent quality, and supports the global pharmaceutical industry’s commitment to patient safety.
The standard’s comprehensive requirements—covering material properties, dimensional accuracy, mechanical performance, sterilization compatibility, and functional characteristics—provide a robust framework for the design, manufacture, and testing of these critical packaging components.
As the pharmaceutical packaging industry continues to evolve, ISO 8872:2022 will serve as the foundational reference for aluminum and aluminum-plastic closures. At Vialab, we remain committed to staying at the forefront of these developments, ensuring that our products meet the highest standards of quality, safety, and performance.
References
- ISO 8872:2022 – Aluminium caps and aluminium/plastic caps for infusion bottles and injection vials — General requirements and test methods
- ISO 10985:2009 – Caps made of aluminium-plastics combinations for infusion bottles and injection vials — Requirements and test methods
- ISO 8362-6 – Injection containers and accessories — Part 6: Caps made of aluminium-plastics combinations for injection vials
- ISO 8536-7 – Infusion equipment for medical use — Part 7: Caps made of aluminium-plastics combinations for infusion bottles
- ISO 6892-1 – Metallic materials — Tensile testing
- ISO 7500-1 – Metallic materials — Calibration and verification of static uniaxial testing machines
- EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
- USP <671> – Containers — Performance Testing
- USP <381> – Elastomeric Closures for Injections
- ISO/TC 76 – Transfusion, infusion and injection, and blood processing equipment for medical and pharmaceutical use
This article is provided for informational purposes only and does not constitute regulatory advice. Manufacturers should consult with qualified experts and regulatory authorities for specific product validation and compliance.